A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Forteo %5Bteriparatide


Cymbalta is bright spot as charges batter Lilly net income  -  Feb 1, 2007
Pharma Times (subscription),The osteoporosis drug Forteo (teriparatide), US sales of which significantly benefited from access to medical coverage through the Medicare Part D programme

Zelos: osteoporosis therapy to face challenge despite positive data  -  Feb 9, 2007
Pharmaceutical Business ReviewEli Lilly's Forteo (teriparatide) was the first drug to be marketed in this class; for the treatment of postmenopausal osteoporosis in women and in men with

Nastech delays osteoporosis nasal spray development  -  Dec 6, 2006
DrugResearcher.com,Eli Lilly is already a player in the osteoporosis market and has already launched a drug – Forteo (teriparatide) – to treat the condition that is delivered

Lilly opts for caution with 2007 earnings estimates  -  Dec 8, 2006
Pharma Times (subscription),...cancer treatment Alimta (pemextred) and Forteo (teriparatide) for osteporosis, while sales of the company's biggest product, the antipsychotic Zyprexa

Research and Markets: Eli Lilly’s Bone-Building Drug Forteo ...  Nov 8, 2006
Eli Lilly’s bone-building drug Forteo (teriparatide) was a promising breakthrough treatment for osteoporosis that achieved disappointing sales and relatively ... -Business Wire (press release), Nastech delays osteoporosis nasal spray development  -  Dec 6, 2006
DrugResearcher.com,Eli Lilly is already a player in the osteoporosis market and has already launched a drug – Forteo (teriparatide) – to treat the condition that is delivered

Lilly opts for caution with 2007 earnings estimates  -  Dec 8, 2006
Pharma Times (subscription),...cancer treatment Alimta (pemextred) and Forteo (teriparatide) for osteporosis, while sales of the company's biggest product, the antipsychotic Zyprexa

An Estimated 10 Million Americans over 50 Suffer from Osteoporosis  -  Nov 13, 2006
TheMatureMarket.com (press release),Most recently the FDA has approved the use of the parathyroid hormone Forteo (teriparatide), the first treatment for osteoporosis with anabolic activity.

Osteogenesis Imperfecta  Jul 27, 2006
...correct bone deformity. Researchers are now looking at a new drug for adults with OI, called Forteo® (teriparatide). Forteo increases ... -WSOCtv.com

Lilly Reports Second-Quarter EPS of $.76  Jul 21, 2006
...tadalafil, ICOS), Lilly ICOS LLC Cymbalta® (duloxetine hydrochloride, Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant ... -Yahoo! News

Nastech's Parathyroid Hormone (PTH1-34) Nasal Spray Demonstrated ...  Jun 26, 2006
...(Nasdaq: NSTK - News) provided comparable exposure levels to the approved subcutaneous product, Forteo® (teriparatide), in elderly subjects, according to data ... -Yahoo! News



Lilly to extend patient assistance programs for Medicare patients  May 11, 2006
A favorable opinion from the OIG would allow Lilly to continue providing Forteo (teriparatide [rDNA origin] injection), a treatment for osteoporosis, and ... - News-Medical.net

Lilly to Extend Patient Assistance Programs for Medicare Patients  May 10, 2006
A favorable opinion from the OIG would allow Lilly to continue providing Forteo® (teriparatide [rDNA origin] injection), a treatment for osteoporosis, and ... - Yahoo! News

Pharmacokinetic Data for Nastech's Intranasal Parathyroid Hormone ...  Apr 28, 2006
...study of Parathyroid Hormone (PTH1-34) nasal spray demonstrating a similar pharmacokinetic profile to the approved subcutaneous product, Forteo® (teriparatide ... - Yahoo! News

Sally Field talks about osteoporosis  Apr 21, 2006
...in November 2002. Forteo (teriparatide) is the first treatment that stimulates new bone growth to increase bone mass. Forteo is ... - Food Consumer





NPS Falls On Preos Approvable Letter; Safety Concerns Cited  Mar 10, 2006
Preos is expected to compete with Indianapolis-based Eli Lilly & Co.’s Forteo (teriparatide), which posted total sales of $118 million for the fourth quarter ... - BioWorld Online (subscription)

[an error occurred while processing this directive]


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional